FDA.reportPublic FDA data

Exforge HCT 10/160/12.5 Oral Tablet

RxCUI
848134
RxNorm name
Exforge HCT 10/160/12.5 Oral Tablet
Display name
Exforge HCT 10/160/12.5 Oral Tablet
Full name
Exforge HCT 10/160/12.5 Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
18d7820d-471f-4ee2-9ec6-25d8d27c77deEXFORGE HCT 10 MG / 160 MG / 12.5 MG Oral Tablet [PSN] · amlodipine 10 MG / hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral Tablet [Exforge HCT] [SBD] · Amlodipine 10 MG / HCTZ 12.5 MG / valsartan 160 MG Oral Tablet [Exforge HCT] [SY] · Exforge HCT 10/160/12.5 (amlodipine / valsartan / HCTZ) Oral Tablet [SY] · Exforge HCT 10/160/12.5 Oral Tablet [SY]533These highlights do not include all the information needed to use EXFORGE HCT safely and effectively. See full prescribing information for EXFORGE HCT. EXFORGE HCT ® (amlodipine, valsartan, and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 200920251212